Results 61 to 70 of about 7,271,399 (244)
Immunosuppressive Drug Use in Limited Systemic Sclerosis: An International Survey
Objective Current guidelines recommend immunosuppressive treatment for diffuse cutaneous systemic sclerosis but are less clear on their use in limited cutaneous systemic sclerosis (lcSSc) in the absence of internal organ complications. We conducted an international survey to understand current immunosuppressive drug prescribing patterns in lcSSc ...
Sabrina Hoa +3 more
wiley +1 more source
Carbon Market Provisions in the Paris Agreement (Article 6). CEPS Special Report No. 128/January 2016 [PDF]
The markets provisions, contained in Article 6 of the Paris Agreement adopted in December 2015, can be seen as both a major success and a minor miracle.
Marcu, Andrei
core
CARBON FOOTPRINT IN THE ECONOMY AND ITS IMPACT ON THE ENVIRONMENT IN THE KYRGYZ REPUBLIC [PDF]
The problem of climate change is now widely discussed by many specialists, scientists and politicians as requiring great efforts from many states. One of the recognized ways of its solution is the scenario of low-carbon economic development, which is ...
Karybaeva Ch. S. +2 more
doaj +1 more source
Objective JAK inhibitors (JAKi) have shown promising effects in early‐phase studies of systemic sclerosis (SSc). We aimed to assess the safety and explore the effectiveness of JAKi compared to conventional immunosuppressants in SSc. Methods A longitudinal retrospective study of the European Scleroderma Trials and Research Group (EUSTAR) cohort was ...
Stefano Di Donato +27 more
wiley +1 more source
Azerbaijan has committed to cut GHG emissions by 35% by 2030 under the Paris Agreement. By applying LEAP, a well-regarded forecasting model based on inventories defined under the IPCC (Intergovernmental Panel on Climate Change), GHG emissions projections
Troy B. Felver
doaj +1 more source
Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS‐DAI)
Objective Vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic syndrome (VEXAS) syndrome is characterized by a complex spectrum of inflammatory and hematologic manifestations. Clinical research to identify effective therapies is urgently needed but is hindered by the lack of validated outcome measures.
Kevin Byram +25 more
wiley +1 more source
Objective Hydroxychloroquine (HCQ) is the cornerstone of systemic lupus erythematosus (SLE) management with benefits extending beyond SLE control, including protection against atherosclerotic cardiovascular disease (ASCVD). Although HCQ blood levels reflect recent exposure and long‐term intake reflects medication adherence, the impact of longitudinal ...
Shivani Garg +5 more
wiley +1 more source
Putting the Paris Agreement at the centre of Europe’s climate and energy map. Egmont Paper 88 , [PDF]
The Paris Agreement, adopted in December 2015, sent a clear message to the world that the global transition to a low-carbon economy is an inevitability that requires commitment from countries but also from businesses, regions, cities and citizens.
d'Oultremont, Clémentine +1 more
core
A simplified thermoplastic pultrusion model is developed to predict thermal fields in glass fiber/polyethylene terephthalate (GF/PET) composites with reduced computational cost. By combining effective material homogenization, validation against literature data, and Gaussian‐process‐based optimization, the study reveals how heating limits, pulling speed,
Elder Soares +3 more
wiley +1 more source
Fostering Innovation: Streamlining Magnetocaloric Materials Research by Digitalization
Magnetocaloric cooling (MCE) is an environmentally friendly refrigeration method with great potential. Optimizing MCE materials involves the preparation and screening of large quantities of samples, which in turn generates a large amount of data. A digitalization approach is presented that uses ontologies, knowledge graphs, and digital workflows to ...
Simon Bekemeier +17 more
wiley +1 more source

